Back to Search
SHELBY JEFFERS, PHARMD
PHARMD
Pharmacist
NPI: 1003591660Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Human coronavirus 229E can use CD209L (L-SIGN) to enter cells.
PMID 17037540·Adv Exp Med Biol·2006
7-preclinical
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus.
PMID 15496474·Proc Natl Acad Sci U S A·2004
7-preclinical
Peptide nanoparticles as novel immunogens: design and analysis of a prototypic severe acute respiratory syndrome vaccine.
PMID 19152635·Chem Biol Drug Des·2009
7-preclinical
SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells.
PMID 18022664·Virology·2008
8-other
Aromatic amino acids in the juxtamembrane domain of severe acute respiratory syndrome coronavirus spike glycoprotein are important for receptor-dependent virus entry and cell-cell fusion.
PMID 18199653·J Virol·2008
8-other
Pregnancy at or beyond age 40 years is associated with an increased risk of fetal death and other adverse outcomes.
PMID 17466664·Am J Obstet Gynecol·2007
8-other
Prevalence of overweight in north Florida elementary and middle school children: effects of age, sex, ethnicity, and socioeconomic status.
PMID 17970867·J Sch Health·2007
8-other
Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus.
PMID 16697221·J Struct Biol·2006
7-preclinical
Phase I clinical and pharmacokinetic trial of docetaxel and irinotecan administered on a weekly schedule.
PMID 15809878·Cancer Chemother Pharmacol·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 223 N Main St
Paris, MO 65275 - Phone
- (660) 327-4514
Quick Facts
- NPI
- 1003591660
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile